Editorials Treatment of leprosy BMJ 2004; 328 doi: https://doi.org/10.1136/bmj.328.7454.1447 (Published 17 June 2004) Cite this as: BMJ 2004;328:1447 Article Related content Metrics Responses Peer review Related articles This Week In The BMJ Steroids do not prevent long term nerve damage in leprosy Published: 17 June 2004; BMJ 328 doi:10.1136/bmj.328.7454.0 Paper Steroid prophylaxis for prevention of nerve function impairment in leprosy: randomised placebo controlled trial (TRIPOD 1) Published: 17 June 2004; BMJ 328 doi:10.1136/bmj.38107.645926.AE PAPERS Steroid prophylaxis for prevention of nerve function impairment in leprosy: randomised placebo controlled trial (TRIPOD 1) Published: 24 May 2004; BMJ doi:10.1136/bmj.38107.645926.AE See more Contaminated blood victims are still being let down by government, say campaigners BMJ April 19, 2024, 385 q909; DOI: https://doi.org/10.1136/bmj.q909 Bird flu: Person with rare strain in US sparks alarm about cow transmission BMJ April 04, 2024, 385 q797; DOI: https://doi.org/10.1136/bmj.q797 Antibiotic costs rise 1100% as big pharma exits Nigeria BMJ March 01, 2024, 384 q328; DOI: https://doi.org/10.1136/bmj.q328 Measles: 500 cases are confirmed in England as clusters appear around the country BMJ February 15, 2024, 384 q417; DOI: https://doi.org/10.1136/bmj.q417 Alaskapox: First human death from zoonotic virus is announced BMJ February 15, 2024, 384 q415; DOI: https://doi.org/10.1136/bmj.q415 Cited by... An unusual cause of mononeuritis multiplexAbstract Fulltext PDF